Erleada 240 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FP8K4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,705
Award facts
- Contract value 100% obligated
- $14,704.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,704.98 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed price structure. This delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through the DLA's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products including brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Erleada delivery represents one component of the company's broader pharmaceutical distribution responsibilities under its prime indefinite delivery vehicle with the DLA.
Quick answers
Who was awarded contract SPE2DB25FP8K4?
SPE2DB25FP8K4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FP8K4 worth?
The government has obligated $14,705 on SPE2DB25FP8K4.
Is contract SPE2DB25FP8K4 an order under another contract?
Yes. SPE2DB25FP8K4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP8K4 competed?
The extent of competition for SPE2DB25FP8K4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award